Key points
- Isomorphic Labs is negotiating to raise approximately $5 billion in new funding.
- The startup is targeting a valuation of roughly $50 billion for this round.
- The company previously raised $2.1 billion in May, according to the published report
Bloomberg reported that Isomorphic Labs, a spinout from Google DeepMind, is in discussions to raise roughly $5 billion.reported The AI drug discovery startup is seeking this capital at a valuation of approximately $50 billion.reportedIsomorphic Labs wants to raise $5 billion to grow its AI drug discovery work.Isomorphic Labs is negotiating a $5B raise at a $50B valuation, per Bloomberg sources. This move follows a significant fundraising event earlier in the year.
Evidence: reported
Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)aifleet-techmeme
Evidence: reported
Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)aifleet-techmeme
What was released or claimed
Bloomberg stated that the company is in talks to secure about $5 billion in new funds.reported The report indicates the startup aims for a $50 billion valuation.reported These figures reflect current negotiations rather than a closed deal.
Evidence: reported
Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)aifleet-techmeme
Evidence: reported
Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)aifleet-techmeme
Who it affects
The news directly concerns Isomorphic Labs and its investors. It also impacts Alphabet Inc., which owns the parent organization Google DeepMind. The broader AI drug discovery sector may feel the effects of such large capital movements.
What is still unknown
The source material does not confirm if the funding round has closed. It does not name the specific investors participating in the talks. Details on how the funds will be allocated beyond general AI efforts are not provided.
The practical upshot
The potential raise signals continued high valuation interest in AI-driven biotechnology. It suggests that investors are willing to back ambitious drug discovery startups with substantial capital. The previous raise in May sets a baseline for growth.
What the rules require
Product teams should note that no official announcement has been made by Isomorphic Labs. Bloomberg attributes the information to sources. Compliance with reporting standards requires treating these figures as unconfirmed negotiations.unverified Teams must wait for official confirmation before adjusting strategies based on this capital injection.
Why it matters
- High valuations in AI drug discovery indicate strong investor confidence in the sector's potential.
- The scale of the raise suggests significant expansion plans for Isomorphic Labs' AI capabilities.
- Alphabet's involvement through Google DeepMind highlights the tech giant's commitment to AI in healthcare.
Topics: AI, drug discovery, funding, Isomorphic Labs, Google DeepMind
Updated
Then / now / next
Isomorphic Labs raised $2.1 billion in May.
The company is negotiating a new round of roughly $5 billion.
Watch for official confirmation of the deal and final valuation terms.
Story timeline
- Then Isomorphic Labs raised $2.1 billion in May.
- 05 Nov 2026 Sources: Google DeepMind spinout Isomorphic Labs is in talks to raise ~$5B at a ~$50B valuation; the AI drug discovery startup last raised $2.1B in May (Bloomberg)
- Now The company is negotiating a new round of roughly $5 billion.
- Next Watch for official confirmation of the deal and final valuation terms.
The strongest doubt
Counterpoint from the sources
The funding round is still in the negotiation phase and has not been officially confirmed by the company.
Numbers in context
Circle area is proportional to the magnitude; labels retain signs. Figures may describe different measures. Read their contexts above.Ask the article
Local keyword search of this article; no generated answers.Did this article give you the evidence you needed?
Your choice stays on this device. No public tally.Terms in this story
Isomorphic Labs
An AI drug discovery startup spun out from Google DeepMind.
Valuation
The estimated market value of a company.
Spinout
A new company formed from a larger parent organization.
Questions readers ask
How much is Isomorphic Labs raising?
The startup is in talks to raise roughly $5 billion, according to the published report
What is the target valuation?
The company is seeking a valuation of approximately $50 billion.
When did they last raise funds?
Isomorphic Labs raised $2.1 billion in May, as according to the published report
Connected stories
Reading receipt
- Isomorphic Labs is negotiating to raise approximately $5 billion in new funding.
- The startup is targeting a valuation of roughly $50 billion for this round.
- The company previously raised $2.1 billion in May, according to the published report
Still open: Has the deal officially closed?
Still open: Who are the lead investors in this round?